4 completed, 1 withdrawn. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow pramlintide: new trials by email Literature Review of pramlintide trials Research Report on pramlintide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus ADO09 formulation, Placebo, Symlin® - Type 1 Diabetes Mellitus | Phase 1 | Completed | Adocia | 24 | 2019-01-04 | 2019-04-16 |
| A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus BC Pram Ins, Symlin® and Humulin®, Humalog® - Type 1 Diabetes Mellitus | Phase 1 | Completed | Adocia | 24 | 2018-04-25 | 2019-02-21 |
| Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus Pramlintide acetate, Placebo, Lispro insulin U-100 - Type 1 Diabetes Mellitus | Phase 1 | Completed | AstraZeneca | 34 | 2015-08-17 | 2018-11-02 |
| Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM Pramlintide acetate, Placebo - Type 1 Diabetes | Phase 1 | Completed | AstraZeneca | 32 | 2012-11-01 | 2014-10-20 |
| Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus Pramlintide - Diabetes Mellitus | Phase 1 / Phase 2 | Withdrawn | University of Colorado, Denver | 2009-08-01 | 2018-07-26 |
Diabetes Mellitus, Type 1 (4) · Diabetes Mellitus (1) · Insulin Resistance (1)
Adocia (2) · AstraZeneca (2) · University of Colorado, Denver (1)
United States (3) · Germany (2)
Grit Andersen, MD (2) · Boris Draznin, M.D., Ph.D. (1) · Peter Ohman, MD (1)